Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma

Journal of Clinical Oncology

Volumn 14, Issue 2, 1996, Pages 405-414

  Meitar, D ^a   Crawford, S E ^a   Rademaker, A W ^a   Cohn, S L ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; METASTASIS; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; TUMOR BLOOD FLOW;

EID: 0030034892     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.2.405     Document Type: Article

References (63)

1. Young JL Jr, Miller RW: Incidence of malignant tumors in U.S. children. J Pediatr 86:254-258, 1975
2. Evans AE, D'Angio GJ, Randolph J: A proposed staging for children with neuroblastoma. Childrens Cancer Study Group A. Cancer 27:374-378, 1971
3. Evans AE, D'Angio GJ, Propert K, et al: Prognostic factors in neuroblastoma. Cancer 59:1853-1859, 1987
4. Nitschke R, Smith EI, Shochat S, et al: Localized neuroblastoma treated by surgery: A Pediatric Oncology Group study. J Clin Oncol 6:1271-1279, 1988
5. Look AT, Haves FA, Shuster JJ, et al: Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 9:581-591, 1991
6. Bowman LC, Hancock ML, Santana VM, et al: Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: The St Jude Children's Research Hospital experience, 1962 to 1988. J Clin Oncol 9:1559-1608, 1991
7. Joshi VV, Cantor AB, Altshuler G, et al: Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the Pediatric Oncology Group. Cancer 69:2197-2211, 1992
8. Shimada H, Chatten J, Newton WA Jr, et al: Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984
9. Look AT, Hayes FA, Nitschke R, et al: Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 311:231-235, 1984
10. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116, 1985
11. Brodeur GM, Seeger RC, Schwab M, et al: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124, 1984
12. Hayashi Y, Kanda N, Inaba T, et al: Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 63:126-132, 1989
13. Fong CT, White PS, Peterson K, et al: Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res 52:1780-1785, 1992
14. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, et al: Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847-854, 1993
15. Suzuki T, Bogenmann E, Shimada H, et al: Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 85:337-384, 1993
16. Borrello MG, Bongarzone I, Pierotti MA, et al: TRK and RET protooncogene expression in human neuroblastoma specimens: high-frequency of TRK expression in non-advanced stages. Int J Cancer 54:540-545, 1993
17. Kogner P, Barbany G, Dominici C, et al: Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res 53:2044-2050, 1993
18. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6, 1990
19. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1:27-31, 1995
20. Liotta LA, Kleinerman J, Saidel GM: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 34:997-1004, 1974
21. Weinstat-Saslow D, Steeg PS: Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J 8:401-407, 1994
22. Srivastava A, Laidler P, Davies RP, et al: The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 133:419-423, 1988
23. Fallowfield ME, Cook MG: The vascularity of primary cutaneous melanoma. J Pathol 164:241-244, 1991
24. Ribatti D, Vacca A, Palma W, et al: Angiogenesis during tumor progression in human malignant melanoma. Experientia 61:415-420, 1992 (suppl)
25. Weidner N, Semple JP, Welch WR, et al: Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N Engl J Med 324:1-8, 1991
26. Weidner N, Folkman J, Pozza F, et al: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875-1887, 1992
27. Toi M, Kashitani J, Tominaga T: Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 55:371-374, 1993
28. Macchiarini P, Fontanini G, Hardin MJ, et al: Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340:145-146, 1992
29. Maeda K, Chung Y-S, Takatsuka S, et al: Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13:477-481, 1995
30. Schmidt ML, Salwen HR, Manohar CF, et al: The biologic effects of antisense N-myc expression in human neuroblastoma. Cell Growth Differ 5:171-178, 1994
31. Mourad MM, Giddings J, Marks R, et al: An immunoradiometric assay for von Willebrand factor antigen to assess angiogenesis. Br J Dermatol 123:21-28, 1990
32. Mehta CR, Patel NR: A network algorithm for performing Fisher's exact test in r x c contingency tables. J Am Stat Assoc 78:427-434, 1983
33. Lee ET: Statistical Methods for Survival Data Analysis (ed 2). New York, NY, Wiley, 1992
34. Bouck N: Tumor angiogenesis: The role of oncogenes and tumor suppressor genes. Cancer Cells 2:179-185, 1990
35. Dameron KM, Volpert OV, Tainsky MA, et al: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265:1582-1584, 1994
36. Rastinejad F, Polverini PJ, Bouck NP: Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56:345-355, 1989
37. Gasparini G, Weidner N, Bevilacqua P, et al: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12:454-466, 1994
38. Weidner N: Tumor angiogenesis: Review of current applications in tumor prognostication. Semin Diagn Pathol 10:302-313, 1993
39. Bosari S, Lee AK, DeLellis RA, et al: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755-761, 1992
40. Yamazaki K, Abe S, Takekawa H, et al: Tumor angiogenesis in human lung adenocarcinoma. Cancer 74:2245-2250, 1994
41. Albo D, Granick MS, Jhala N, et al: The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck. Ann Plast Surg 32:588-594, 1994
42. Weidner N, Carroll PR, Flax J, et al: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409, 1993
43. Williams JK, Carlson GW, Cohen C, et al: Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 168:373-380, 1994
44. Kerbel RS, Waghorne C, Korczak B, et al: Clonal dominance of primary tumours by metastatic cells: Genetic analysis and biological implications. Cancer Surv 7:597-629, 1988
45. Horak ER, Leek R, Klenk N, et al: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340:1120-1124, 1992
46. Vermeulen PB, Verhoeven D, Fierens H, et al: Microvessel quantification in primary colorectal carcinoma: An immunohistochemical study. Br J Cancer 71:340-343, 1995
47. Takahashi A, Sasaki H, Kim SJ, et al: Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54:4233-4237, 1994
48. Joshi VV: Small round cell tumors and related lesions in children, in Joshi VV (ed): Common Problems in Pediatric Pathology. New York, NY, Igaku-Shoin, 1994, pp 360-381
49. Schweigerer L, Breit S, Wenzel A, et al: Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: Evidence for induction of autocrine growth factor activity. Cancer Res 50:4411-4416, 1990
50. Bernards R, Dessain SK, Weinberg RA: N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Cell 47:667-674, 1986
51. Negroni A, Scarpa S, Romeo A, et al: Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ 2:511-518, 1991
52. Blackwood EM, Eisenman RN: Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-1217, 1991
53. Blackwell TK, Kretzner L, Blackwood EM, et al: Sequence-specific DNA binding by the c-Myc protein. Science 250:1149-1151, 1990
54. Cohn SL, Look AT, Joshi VV, et al: Lack of correlation of N-myc gene amplification with prognosis in localized neuroblasotma: A Pediatric Oncology Group study. Cancer Res 55:721-726, 1995
55. Evans AE, Gerson J, Schnaufer L: Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr 44:49-54, 1976
56. D'Angio GJ, Evans AE, Koop CE: Special pattern of wide-spread neuroblastoma with a favourable prognosis. Lancet 1:1046-1049, 1971
57. Wilson LM, Draper GJ: Neuroblastoma, its natural history and prognosis: A study of 487 cases. Br Med J 3:301-307, 1974
58. Breslow N, McCann B: Statistical estimation of prognosis for children with neuroblastoma. Cancer Res 31:2098-2103, 1971
59. Cohn SL, Rademaker AW, Salwen HR, et al: Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma. Am J Pathol 136:1043-1052, 1990
60. Tsuda T, Obara M, Hirano H, et al: Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas. Cancer 60:820-826, 1987
61. Bonilla MA, Cheung N-KV: Clinical progress in neuroblastoma. Cancer Invest 12:644-653, 1994
62. Ingber D, Fujita T, Kishimoto S, et al: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348:555-557, 1990
63. O'Reilly MS, Holmgren L, Shing Y, et al: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328, 1994